A ‘once-in-a-generation’ chance to reset vaccine innovation in Canada
The experience of Connaught Labs offers lessons for Canada's new Sanofi deal to manufacture vaccines in Canada, and it doesn't appear the government has learned much from it.
A woman, pictured July 20, 2020, walking down Wellington Street in Ottawa. Before COVID-19, industry had shown little interest in developing treatments against coronaviruses. This led many to suggest that we should rethink how we encourage biopharmaceutical innovation for public health emergencies. The Hill Times photograph by Andrew Meade